Diacerein is the first interleukin 1 (Il-1) inhibitor in osteoarthritis. It is indicated for the treatment of degenerative joint diseases (osteoarthritis and related diseases).

Diacerein is effective in reducing pain and functional impairment, the major symptoms of OA, and has shown structure-modifying effects with good gastrointestinal tolerability.